Am J Psychiatry 1988; 145:748-750
Copyright © 1988 by American Psychiatric Association
A carbamazepine trial in chronic, treatment-refractory schizophrenia
J Sramek, J Herrera, J Costa, C Heh, T Tran-Johnson and G Simpson
Clinical Research Unit, Metropolitan State Hospital, Norwalk, CA 90650.
Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic
patients for 5 weeks. No overall change was found, but four patients
significantly improved while eight worsened. Given the paucity of
successful treatments for refractory schizophrenia, further study of
carbamazepine appears warranted.